Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06386861 · ClinicalTrials.gov registry record · NA
Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM).
A NA study of Adult ALL, sponsored by Boston College.
- Active
- Registry status
- NA
- Development phase
- 851
- Enrollment target
- 1
- Study location
NCT06386861: Active NA study of Adult ALL, sponsored by Boston College.
NCT06386861 is a NA study of Adult ALL that is active but no longer recruiting, run by Boston College. The registered enrollment target is 851 participants, above the 33-participant average among 3 other Adult ALL trials with a reported enrollment target (2479% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06386861, a NA study of Adult ALL, is active but no longer recruiting, sponsored by Boston College.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 851 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to evaluate English and Spanish versions of the "Attitudes toward genomics and precision medicine" instrument (AGPM). This study will help validating a Spanish version of the AGPM among people identifying as Hispanic, Latino, or Latina. Having a valid instrument is important for developing tailored interventions to decrease disparities in genomic healthcare for this population.
Primary Outcome
Establish the psychometric properties of the translated AGPM
Conditions Studied
Interventions
- OTHER Attitudes Toward Genomics and Precision Medicine (English)
- OTHER Attitudes Toward Genomics and Precision Medicine (Spanish)
Study Locations (1)
Massachusetts
- Boston College - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 851 participants |
| Start Date | 2024-04-14 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT06386861 still lists
NCT06386861 is an interventional study that assigns participants to a tested intervention. The registered 851 participants enrollment target is mid-sized for trials with a published cap, above the 33-participant average among 3 other Adult ALL trials with a reported enrollment target (2479% higher).
The record links to 1 condition, with Adult ALL appearing as the primary indexed condition, and to 2 interventions - of which Attitudes Toward Genomics and Precision Medicine (English) is the first listed.
NCT06386861 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06386861 about?
NCT06386861 is a clinical study titled "Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM).". The investigators aim to evaluate English and Spanish versions of the "Attitudes toward genomics and precision medicine" instrument (AGPM). This study will help validating a Spanish version of the AGPM among people identifying as Hispanic, Latino, or Latina. Having a valid instrument is important fo...
What is the current status of trial NCT06386861?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 851 participants. The study started on 2024-04-14. Estimated completion is 2025-12-31.
What conditions does trial NCT06386861 study?
This clinical trial studies the following conditions: Adult ALL.
What interventions are being tested in trial NCT06386861?
The interventions under investigation include: Attitudes Toward Genomics and Precision Medicine (English) (OTHER), Attitudes Toward Genomics and Precision Medicine (Spanish) (OTHER).
Who is sponsoring clinical trial NCT06386861?
This trial is sponsored by Boston College, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06386861 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adult ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06422143 · 851 participants · Phase 3
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- NCT06237452 · 852 participants · Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI